| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunity, Innate | 22 | 2025 | 433 | 4.310 |
Why?
|
| Selection, Genetic | 20 | 2024 | 512 | 3.600 |
Why?
|
| Mycobacterium tuberculosis | 20 | 2024 | 195 | 3.080 |
Why?
|
| Epigenesis, Genetic | 12 | 2024 | 517 | 3.010 |
Why?
|
| Tuberculosis | 16 | 2024 | 121 | 2.890 |
Why?
|
| Genetics, Population | 13 | 2024 | 407 | 2.810 |
Why?
|
| Evolution, Molecular | 15 | 2018 | 851 | 1.790 |
Why?
|
| Lectins, C-Type | 8 | 2009 | 86 | 1.750 |
Why?
|
| Immunologic Memory | 6 | 2024 | 163 | 1.610 |
Why?
|
| Primates | 3 | 2021 | 155 | 1.520 |
Why?
|
| Macrophages | 9 | 2024 | 578 | 1.460 |
Why?
|
| Leukocytes, Mononuclear | 7 | 2024 | 204 | 1.430 |
Why?
|
| Cell Adhesion Molecules | 7 | 2009 | 167 | 1.430 |
Why?
|
| Genetic Variation | 16 | 2024 | 1380 | 1.410 |
Why?
|
| Immune System | 4 | 2020 | 97 | 1.400 |
Why?
|
| BCG Vaccine | 4 | 2024 | 35 | 1.390 |
Why?
|
| Receptors, Cell Surface | 7 | 2009 | 288 | 1.360 |
Why?
|
| Genome, Human | 14 | 2024 | 791 | 1.340 |
Why?
|
| Dendritic Cells | 10 | 2019 | 451 | 1.330 |
Why?
|
| Bacteria | 6 | 2023 | 481 | 1.330 |
Why?
|
| Immunity | 7 | 2024 | 141 | 1.280 |
Why?
|
| Genetic Predisposition to Disease | 15 | 2024 | 2354 | 1.250 |
Why?
|
| Vaccination | 5 | 2024 | 277 | 1.230 |
Why?
|
| Papio | 6 | 2023 | 82 | 1.210 |
Why?
|
| Animals | 64 | 2025 | 27476 | 1.140 |
Why?
|
| Gastrointestinal Microbiome | 8 | 2023 | 516 | 1.120 |
Why?
|
| Lactase | 2 | 2024 | 5 | 1.060 |
Why?
|
| Influenza, Human | 3 | 2024 | 340 | 1.040 |
Why?
|
| Host-Pathogen Interactions | 6 | 2021 | 237 | 1.010 |
Why?
|
| Humans | 110 | 2024 | 89567 | 1.000 |
Why?
|
| Hematopoietic Stem Cells | 5 | 2025 | 305 | 0.970 |
Why?
|
| Gene Expression Profiling | 12 | 2024 | 1445 | 0.930 |
Why?
|
| Gene Expression Regulation | 16 | 2023 | 1982 | 0.920 |
Why?
|
| Immunity, Cellular | 3 | 2016 | 178 | 0.880 |
Why?
|
| Bacterial Infections | 7 | 2023 | 184 | 0.870 |
Why?
|
| Adaptation, Physiological | 5 | 2021 | 314 | 0.800 |
Why?
|
| Tuberculosis, Pulmonary | 4 | 2016 | 58 | 0.750 |
Why?
|
| Sepsis | 3 | 2024 | 326 | 0.740 |
Why?
|
| Biological Evolution | 6 | 2024 | 967 | 0.740 |
Why?
|
| Mycobacterium bovis | 2 | 2018 | 16 | 0.730 |
Why?
|
| Immunity, Herd | 1 | 2020 | 2 | 0.720 |
Why?
|
| Viruses | 1 | 2021 | 78 | 0.710 |
Why?
|
| Quantitative Trait Loci | 11 | 2024 | 613 | 0.710 |
Why?
|
| Autoimmune Diseases | 3 | 2023 | 250 | 0.710 |
Why?
|
| Multifactorial Inheritance | 2 | 2019 | 173 | 0.700 |
Why?
|
| Signal Transduction | 11 | 2024 | 3395 | 0.700 |
Why?
|
| Polymorphism, Single Nucleotide | 16 | 2024 | 2411 | 0.700 |
Why?
|
| Models, Immunological | 1 | 2020 | 81 | 0.690 |
Why?
|
| Lipopolysaccharides | 7 | 2024 | 294 | 0.680 |
Why?
|
| Disease Susceptibility | 6 | 2024 | 200 | 0.670 |
Why?
|
| Environment | 1 | 2021 | 223 | 0.670 |
Why?
|
| Genetic Loci | 5 | 2017 | 253 | 0.660 |
Why?
|
| Chromatin | 5 | 2024 | 401 | 0.650 |
Why?
|
| Inflammation | 9 | 2024 | 975 | 0.650 |
Why?
|
| Energy Metabolism | 1 | 2021 | 280 | 0.650 |
Why?
|
| Genome | 6 | 2024 | 391 | 0.640 |
Why?
|
| Gene Expression | 4 | 2019 | 1309 | 0.640 |
Why?
|
| Macaca mulatta | 8 | 2022 | 466 | 0.620 |
Why?
|
| DNA, Mitochondrial | 1 | 2019 | 189 | 0.610 |
Why?
|
| Transcriptome | 7 | 2024 | 654 | 0.600 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 182 | 0.590 |
Why?
|
| Latent Tuberculosis | 1 | 2017 | 16 | 0.580 |
Why?
|
| Rainforest | 6 | 2019 | 9 | 0.580 |
Why?
|
| Chiroptera | 1 | 2018 | 54 | 0.570 |
Why?
|
| Epigenomics | 5 | 2024 | 103 | 0.550 |
Why?
|
| Immune Tolerance | 5 | 2025 | 341 | 0.550 |
Why?
|
| Species Specificity | 5 | 2024 | 685 | 0.540 |
Why?
|
| High-Throughput Screening Assays | 2 | 2024 | 58 | 0.530 |
Why?
|
| Toll-Like Receptors | 4 | 2013 | 92 | 0.530 |
Why?
|
| Social Class | 1 | 2016 | 137 | 0.530 |
Why?
|
| Leprosy | 3 | 2017 | 8 | 0.530 |
Why?
|
| Microbiota | 4 | 2024 | 406 | 0.510 |
Why?
|
| Base Pairing | 1 | 2015 | 57 | 0.510 |
Why?
|
| Cytosine | 2 | 2015 | 129 | 0.510 |
Why?
|
| DNA Methylation | 6 | 2024 | 660 | 0.500 |
Why?
|
| Heart | 1 | 2018 | 574 | 0.500 |
Why?
|
| Social Behavior | 4 | 2022 | 299 | 0.500 |
Why?
|
| Orthomyxoviridae Infections | 3 | 2025 | 48 | 0.490 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 319 | 0.490 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 305 | 0.490 |
Why?
|
| Celiac Disease | 5 | 2020 | 214 | 0.490 |
Why?
|
| Mice, Inbred C57BL | 11 | 2025 | 3237 | 0.480 |
Why?
|
| RNA, Untranslated | 3 | 2011 | 65 | 0.480 |
Why?
|
| Immunogenetic Phenomena | 1 | 2014 | 5 | 0.480 |
Why?
|
| Antiviral Agents | 1 | 2018 | 481 | 0.480 |
Why?
|
| Influenza A virus | 3 | 2025 | 172 | 0.470 |
Why?
|
| Sequence Analysis, DNA | 11 | 2022 | 868 | 0.460 |
Why?
|
| Gene Flow | 4 | 2019 | 93 | 0.460 |
Why?
|
| Prefrontal Cortex | 1 | 2015 | 136 | 0.460 |
Why?
|
| Male | 34 | 2024 | 42464 | 0.450 |
Why?
|
| Macrophages, Alveolar | 3 | 2023 | 57 | 0.450 |
Why?
|
| Female | 36 | 2024 | 46371 | 0.450 |
Why?
|
| Phenotype | 6 | 2024 | 2447 | 0.450 |
Why?
|
| Plague | 2 | 2023 | 27 | 0.420 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 316 | 0.420 |
Why?
|
| Mycobacterium leprae | 3 | 2017 | 6 | 0.420 |
Why?
|
| Chytridiomycota | 1 | 2012 | 2 | 0.420 |
Why?
|
| Social Dominance | 3 | 2024 | 30 | 0.420 |
Why?
|
| Ranidae | 1 | 2012 | 5 | 0.410 |
Why?
|
| Neutrophils | 2 | 2025 | 311 | 0.410 |
Why?
|
| Periodicals as Topic | 1 | 2014 | 168 | 0.410 |
Why?
|
| Feces | 6 | 2021 | 331 | 0.400 |
Why?
|
| Xenopus | 1 | 2012 | 126 | 0.400 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2012 | 2 | 0.400 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2012 | 4 | 0.400 |
Why?
|
| Transcription, Genetic | 8 | 2021 | 1158 | 0.400 |
Why?
|
| Mycoses | 1 | 2012 | 46 | 0.400 |
Why?
|
| MicroRNAs | 3 | 2015 | 555 | 0.390 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2024 | 447 | 0.390 |
Why?
|
| NFATC Transcription Factors | 1 | 2011 | 49 | 0.390 |
Why?
|
| Transcription Factors | 9 | 2023 | 1662 | 0.390 |
Why?
|
| Immune System Diseases | 2 | 2023 | 27 | 0.380 |
Why?
|
| Gene Frequency | 4 | 2024 | 687 | 0.370 |
Why?
|
| Gene-Environment Interaction | 3 | 2024 | 117 | 0.370 |
Why?
|
| Adaptive Immunity | 3 | 2021 | 167 | 0.370 |
Why?
|
| Glutens | 4 | 2020 | 84 | 0.360 |
Why?
|
| Mice | 19 | 2025 | 11828 | 0.350 |
Why?
|
| Genomics | 2 | 2024 | 774 | 0.350 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2010 | 124 | 0.340 |
Why?
|
| Cell Differentiation | 4 | 2024 | 1529 | 0.340 |
Why?
|
| Gene Ontology | 4 | 2018 | 34 | 0.330 |
Why?
|
| Interferons | 3 | 2024 | 127 | 0.330 |
Why?
|
| Pan troglodytes | 4 | 2024 | 202 | 0.330 |
Why?
|
| Interleukin-15 | 2 | 2020 | 73 | 0.330 |
Why?
|
| Adult | 17 | 2024 | 26684 | 0.330 |
Why?
|
| Cell Nucleus | 1 | 2011 | 601 | 0.330 |
Why?
|
| HIV-1 | 2 | 2008 | 167 | 0.330 |
Why?
|
| Computational Biology | 3 | 2018 | 549 | 0.330 |
Why?
|
| Molecular Probes | 1 | 2009 | 35 | 0.320 |
Why?
|
| Skin | 1 | 2012 | 589 | 0.320 |
Why?
|
| Colitis | 1 | 2011 | 246 | 0.310 |
Why?
|
| Lymphocyte Activation | 2 | 2021 | 754 | 0.310 |
Why?
|
| Promoter Regions, Genetic | 3 | 2014 | 961 | 0.300 |
Why?
|
| Genotype | 7 | 2021 | 1853 | 0.300 |
Why?
|
| Agriculture | 3 | 2019 | 39 | 0.300 |
Why?
|
| Metagenome | 2 | 2022 | 105 | 0.290 |
Why?
|
| HIV Infections | 3 | 2021 | 846 | 0.290 |
Why?
|
| Receptors, Antigen, T-Cell | 4 | 2022 | 394 | 0.280 |
Why?
|
| Mitochondria | 2 | 2022 | 554 | 0.280 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2006 | 147 | 0.280 |
Why?
|
| Seasons | 2 | 2021 | 239 | 0.270 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 4 | 2020 | 154 | 0.270 |
Why?
|
| Microglia | 2 | 2017 | 108 | 0.270 |
Why?
|
| Interleukin-1beta | 2 | 2024 | 82 | 0.270 |
Why?
|
| Cells, Cultured | 5 | 2018 | 2884 | 0.260 |
Why?
|
| Bone Marrow | 2 | 2024 | 443 | 0.260 |
Why?
|
| Symbiosis | 2 | 2024 | 127 | 0.260 |
Why?
|
| Chromosome Mapping | 2 | 2024 | 1074 | 0.250 |
Why?
|
| Gastrointestinal Tract | 3 | 2020 | 191 | 0.250 |
Why?
|
| beta-Glucans | 1 | 2025 | 7 | 0.250 |
Why?
|
| Antigens, Bacterial | 2 | 2017 | 136 | 0.240 |
Why?
|
| Monocytes | 3 | 2017 | 220 | 0.240 |
Why?
|
| Herpestidae | 1 | 2024 | 1 | 0.240 |
Why?
|
| Uganda | 3 | 2019 | 37 | 0.240 |
Why?
|
| Alendronate | 1 | 2024 | 13 | 0.230 |
Why?
|
| Oxadiazoles | 1 | 2024 | 38 | 0.230 |
Why?
|
| Neanderthals | 2 | 2021 | 16 | 0.230 |
Why?
|
| Cell Line | 7 | 2019 | 2494 | 0.230 |
Why?
|
| Antitubercular Agents | 1 | 2024 | 53 | 0.230 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2024 | 101 | 0.230 |
Why?
|
| DNA Transposable Elements | 2 | 2020 | 175 | 0.230 |
Why?
|
| Small Molecule Libraries | 1 | 2024 | 65 | 0.230 |
Why?
|
| CpG Islands | 3 | 2019 | 158 | 0.220 |
Why?
|
| Behavior, Animal | 3 | 2019 | 378 | 0.220 |
Why?
|
| Pluripotent Stem Cells | 1 | 2023 | 34 | 0.220 |
Why?
|
| Zinc | 1 | 2024 | 94 | 0.220 |
Why?
|
| Diet | 3 | 2022 | 443 | 0.220 |
Why?
|
| Lung | 4 | 2025 | 1273 | 0.220 |
Why?
|
| Individuality | 1 | 2024 | 110 | 0.220 |
Why?
|
| 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid | 1 | 2023 | 2 | 0.220 |
Why?
|
| Virus Diseases | 3 | 2019 | 98 | 0.210 |
Why?
|
| GATA4 Transcription Factor | 1 | 2023 | 19 | 0.210 |
Why?
|
| Cell Self Renewal | 1 | 2023 | 20 | 0.210 |
Why?
|
| Farmers | 3 | 2019 | 5 | 0.210 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2023 | 51 | 0.210 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2023 | 24 | 0.210 |
Why?
|
| Killer Cells, Natural | 3 | 2022 | 276 | 0.210 |
Why?
|
| Interleukins | 2 | 2022 | 131 | 0.210 |
Why?
|
| Yersinia pestis | 1 | 2022 | 24 | 0.210 |
Why?
|
| DNA, Ancient | 1 | 2022 | 18 | 0.210 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2022 | 17 | 0.210 |
Why?
|
| Lymphopenia | 1 | 2022 | 30 | 0.210 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2022 | 488 | 0.210 |
Why?
|
| Environmental Exposure | 2 | 2024 | 330 | 0.200 |
Why?
|
| Antibodies, Viral | 1 | 2024 | 311 | 0.200 |
Why?
|
| Intestinal Mucosa | 3 | 2023 | 805 | 0.200 |
Why?
|
| DNA-Binding Proteins | 2 | 2018 | 1243 | 0.200 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2022 | 597 | 0.200 |
Why?
|
| Cytokines | 2 | 2024 | 806 | 0.200 |
Why?
|
| Heredity | 1 | 2022 | 19 | 0.200 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2021 | 8 | 0.200 |
Why?
|
| Actinobacteria | 1 | 2021 | 11 | 0.190 |
Why?
|
| Firmicutes | 1 | 2021 | 15 | 0.190 |
Why?
|
| Mutation | 8 | 2018 | 4159 | 0.190 |
Why?
|
| Phylogeny | 5 | 2017 | 1191 | 0.190 |
Why?
|
| Life Style | 2 | 2019 | 174 | 0.190 |
Why?
|
| Hematopoiesis | 2 | 2023 | 168 | 0.190 |
Why?
|
| Binding Sites | 4 | 2018 | 1120 | 0.190 |
Why?
|
| Bacteroidetes | 1 | 2021 | 39 | 0.190 |
Why?
|
| Myelopoiesis | 1 | 2020 | 10 | 0.180 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2021 | 106 | 0.180 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2014 | 312 | 0.180 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2021 | 135 | 0.180 |
Why?
|
| Case-Control Studies | 6 | 2019 | 1862 | 0.180 |
Why?
|
| Histones | 1 | 2023 | 333 | 0.180 |
Why?
|
| Adaptation, Biological | 2 | 2019 | 85 | 0.180 |
Why?
|
| Vaccination Coverage | 1 | 2020 | 5 | 0.180 |
Why?
|
| Basic Reproduction Number | 1 | 2020 | 6 | 0.180 |
Why?
|
| Population | 4 | 2011 | 36 | 0.180 |
Why?
|
| Glucocorticoids | 2 | 2022 | 357 | 0.180 |
Why?
|
| Primate Diseases | 1 | 2019 | 4 | 0.170 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2019 | 12 | 0.170 |
Why?
|
| HLA-DQ Antigens | 1 | 2020 | 51 | 0.170 |
Why?
|
| Lentivirus | 1 | 2019 | 43 | 0.170 |
Why?
|
| Interferon Regulatory Factor-1 | 2 | 2017 | 19 | 0.170 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2020 | 69 | 0.170 |
Why?
|
| Software | 1 | 2024 | 666 | 0.170 |
Why?
|
| Antigens | 2 | 2019 | 229 | 0.170 |
Why?
|
| Cell Proliferation | 4 | 2020 | 1668 | 0.170 |
Why?
|
| Alleles | 6 | 2021 | 1136 | 0.170 |
Why?
|
| DNA Demethylation | 1 | 2019 | 1 | 0.170 |
Why?
|
| Transduction, Genetic | 1 | 2019 | 160 | 0.170 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2021 | 276 | 0.170 |
Why?
|
| Benzodiazepines | 1 | 2019 | 69 | 0.160 |
Why?
|
| Antibodies | 1 | 2021 | 353 | 0.160 |
Why?
|
| Genome-Wide Association Study | 4 | 2015 | 1685 | 0.160 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 2384 | 0.160 |
Why?
|
| Principal Component Analysis | 2 | 2017 | 160 | 0.160 |
Why?
|
| Transcriptional Activation | 1 | 2020 | 294 | 0.160 |
Why?
|
| Egypt | 1 | 2018 | 13 | 0.160 |
Why?
|
| Growth Hormone | 1 | 2018 | 96 | 0.160 |
Why?
|
| Global Health | 1 | 2020 | 192 | 0.160 |
Why?
|
| Middle Aged | 8 | 2024 | 25996 | 0.160 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2018 | 78 | 0.160 |
Why?
|
| Acclimatization | 1 | 2018 | 76 | 0.160 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 67 | 0.150 |
Why?
|
| Bayes Theorem | 3 | 2015 | 375 | 0.150 |
Why?
|
| Genetic Vectors | 1 | 2019 | 446 | 0.150 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2019 | 105 | 0.150 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2018 | 42 | 0.150 |
Why?
|
| Chronic Disease | 3 | 2019 | 952 | 0.150 |
Why?
|
| Asymptomatic Diseases | 1 | 2018 | 45 | 0.150 |
Why?
|
| Acetylmuramyl-Alanyl-Isoglutamine | 1 | 2017 | 4 | 0.150 |
Why?
|
| Protein Binding | 3 | 2021 | 1491 | 0.150 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2017 | 21 | 0.150 |
Why?
|
| RNA, Double-Stranded | 1 | 2017 | 23 | 0.150 |
Why?
|
| 5-Methylcytosine | 2 | 2015 | 117 | 0.150 |
Why?
|
| France | 1 | 2017 | 49 | 0.150 |
Why?
|
| Reoviridae Infections | 1 | 2017 | 7 | 0.140 |
Why?
|
| Exome | 1 | 2018 | 131 | 0.140 |
Why?
|
| Interferon-gamma | 3 | 2020 | 449 | 0.140 |
Why?
|
| Epithelial Cells | 1 | 2021 | 688 | 0.140 |
Why?
|
| Base Sequence | 5 | 2016 | 2329 | 0.140 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 2016 | 9 | 0.140 |
Why?
|
| Abnormalities, Multiple | 1 | 2018 | 234 | 0.140 |
Why?
|
| RNA, Messenger | 3 | 2019 | 2021 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 262 | 0.140 |
Why?
|
| Young Adult | 4 | 2024 | 6362 | 0.140 |
Why?
|
| Models, Genetic | 6 | 2014 | 947 | 0.140 |
Why?
|
| Cluster Analysis | 2 | 2015 | 370 | 0.140 |
Why?
|
| Molecular Sequence Data | 6 | 2014 | 3024 | 0.140 |
Why?
|
| Population Dynamics | 3 | 2018 | 137 | 0.140 |
Why?
|
| Brain | 2 | 2017 | 2294 | 0.140 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2023 | 582 | 0.140 |
Why?
|
| Alu Elements | 1 | 2016 | 16 | 0.140 |
Why?
|
| Leukocyte Count | 1 | 2016 | 223 | 0.140 |
Why?
|
| Animals, Wild | 1 | 2016 | 41 | 0.140 |
Why?
|
| Pituitary-Adrenal System | 1 | 2016 | 64 | 0.130 |
Why?
|
| Aging | 1 | 2021 | 721 | 0.130 |
Why?
|
| Adjuvants, Immunologic | 1 | 2017 | 169 | 0.130 |
Why?
|
| South Africa | 2 | 2006 | 60 | 0.130 |
Why?
|
| Transforming Growth Factor beta | 1 | 2018 | 326 | 0.130 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2016 | 81 | 0.130 |
Why?
|
| Exons | 2 | 2015 | 453 | 0.130 |
Why?
|
| Th1 Cells | 1 | 2017 | 166 | 0.130 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2016 | 91 | 0.130 |
Why?
|
| Astrocytes | 1 | 2016 | 142 | 0.130 |
Why?
|
| Mycobacterium smegmatis | 1 | 2015 | 6 | 0.130 |
Why?
|
| Yersinia pseudotuberculosis | 1 | 2015 | 6 | 0.130 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2018 | 35 | 0.130 |
Why?
|
| Staphylococcus epidermidis | 1 | 2015 | 15 | 0.130 |
Why?
|
| Leukemia | 1 | 2018 | 322 | 0.130 |
Why?
|
| Sheep | 3 | 2024 | 251 | 0.130 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 398 | 0.130 |
Why?
|
| Specimen Handling | 1 | 2016 | 103 | 0.130 |
Why?
|
| HLA Antigens | 1 | 2017 | 227 | 0.130 |
Why?
|
| Salmonella typhimurium | 1 | 2015 | 33 | 0.130 |
Why?
|
| Cell Culture Techniques | 1 | 2016 | 194 | 0.130 |
Why?
|
| Leukocytes | 1 | 2016 | 208 | 0.130 |
Why?
|
| Interferon Regulatory Factors | 1 | 2016 | 69 | 0.130 |
Why?
|
| X Chromosome Inactivation | 1 | 2015 | 28 | 0.130 |
Why?
|
| Language | 1 | 2017 | 156 | 0.130 |
Why?
|
| Chromosomes, Human | 1 | 2015 | 65 | 0.130 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2022 | 888 | 0.130 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 979 | 0.120 |
Why?
|
| Annexin A1 | 1 | 2014 | 5 | 0.120 |
Why?
|
| Personality | 1 | 2016 | 134 | 0.120 |
Why?
|
| Virus Physiological Phenomena | 1 | 2014 | 8 | 0.120 |
Why?
|
| Haplotypes | 6 | 2016 | 636 | 0.120 |
Why?
|
| Cross-Priming | 1 | 2014 | 49 | 0.120 |
Why?
|
| Hydrocortisone | 1 | 2016 | 301 | 0.120 |
Why?
|
| Interferon Type I | 3 | 2021 | 186 | 0.120 |
Why?
|
| Zoonoses | 1 | 2014 | 26 | 0.120 |
Why?
|
| Cell Transplantation | 1 | 2014 | 47 | 0.120 |
Why?
|
| Phagocytosis | 1 | 2014 | 86 | 0.120 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily D | 1 | 2014 | 7 | 0.120 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily C | 1 | 2014 | 8 | 0.120 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2018 | 665 | 0.120 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2014 | 3 | 0.120 |
Why?
|
| Introns | 1 | 2015 | 301 | 0.120 |
Why?
|
| Metagenomics | 1 | 2015 | 92 | 0.120 |
Why?
|
| Growth Disorders | 1 | 2014 | 63 | 0.120 |
Why?
|
| Adenosine Monophosphate | 1 | 2014 | 27 | 0.120 |
Why?
|
| Polymorphism, Genetic | 2 | 2009 | 825 | 0.120 |
Why?
|
| Proteome | 3 | 2024 | 135 | 0.120 |
Why?
|
| Anxiety | 1 | 2016 | 310 | 0.120 |
Why?
|
| Dog Diseases | 1 | 2014 | 35 | 0.120 |
Why?
|
| Pandemics | 1 | 2020 | 775 | 0.110 |
Why?
|
| Forests | 1 | 2014 | 22 | 0.110 |
Why?
|
| Body Size | 1 | 2014 | 93 | 0.110 |
Why?
|
| Social Environment | 1 | 2015 | 187 | 0.110 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2014 | 43 | 0.110 |
Why?
|
| Cytoplasm | 1 | 2014 | 285 | 0.110 |
Why?
|
| Gorilla gorilla | 1 | 2013 | 43 | 0.110 |
Why?
|
| Nerve Degeneration | 1 | 2013 | 83 | 0.110 |
Why?
|
| High Mobility Group Proteins | 1 | 2013 | 27 | 0.110 |
Why?
|
| Sex Characteristics | 1 | 2015 | 327 | 0.110 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2015 | 383 | 0.110 |
Why?
|
| Kinetics | 2 | 2020 | 1534 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2013 | 84 | 0.100 |
Why?
|
| Phagosomes | 1 | 2012 | 39 | 0.100 |
Why?
|
| Membrane Microdomains | 1 | 2012 | 54 | 0.100 |
Why?
|
| Ecosystem | 1 | 2015 | 350 | 0.100 |
Why?
|
| Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | 1 | 2011 | 5 | 0.100 |
Why?
|
| Codon, Nonsense | 1 | 2011 | 44 | 0.100 |
Why?
|
| Lysosomes | 1 | 2012 | 113 | 0.100 |
Why?
|
| Armadillo Domain Proteins | 1 | 2011 | 3 | 0.100 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2011 | 11 | 0.100 |
Why?
|
| Toll-Like Receptor 6 | 1 | 2011 | 5 | 0.100 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2011 | 7 | 0.100 |
Why?
|
| Necrosis | 2 | 2023 | 210 | 0.090 |
Why?
|
| Intestine, Small | 2 | 2023 | 299 | 0.090 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2011 | 50 | 0.090 |
Why?
|
| Genetic Linkage | 1 | 2013 | 624 | 0.090 |
Why?
|
| DNA Primers | 2 | 2009 | 543 | 0.090 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2011 | 49 | 0.090 |
Why?
|
| Receptors, Interferon | 1 | 2011 | 33 | 0.090 |
Why?
|
| Bone Marrow Cells | 2 | 2023 | 262 | 0.090 |
Why?
|
| Organ Transplantation | 1 | 2014 | 280 | 0.090 |
Why?
|
| Linear Models | 1 | 2012 | 421 | 0.090 |
Why?
|
| Proteomics | 1 | 2012 | 231 | 0.090 |
Why?
|
| Healthy Volunteers | 2 | 2024 | 146 | 0.090 |
Why?
|
| RNA, Long Noncoding | 1 | 2011 | 120 | 0.090 |
Why?
|
| Mutation, Missense | 1 | 2011 | 280 | 0.090 |
Why?
|
| Cytoskeletal Proteins | 1 | 2011 | 228 | 0.090 |
Why?
|
| Mice, Knockout | 3 | 2025 | 2012 | 0.090 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2009 | 3 | 0.080 |
Why?
|
| Sperm Count | 1 | 2009 | 9 | 0.080 |
Why?
|
| Ferredoxin-NADP Reductase | 1 | 2009 | 15 | 0.080 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2009 | 27 | 0.080 |
Why?
|
| Human Migration | 2 | 2021 | 26 | 0.080 |
Why?
|
| Gene Regulatory Networks | 1 | 2012 | 309 | 0.080 |
Why?
|
| Folic Acid | 1 | 2009 | 63 | 0.080 |
Why?
|
| Epistasis, Genetic | 1 | 2009 | 90 | 0.080 |
Why?
|
| Grooming | 2 | 2022 | 17 | 0.080 |
Why?
|
| Biodiversity | 3 | 2016 | 208 | 0.080 |
Why?
|
| Membrane Glycoproteins | 1 | 2011 | 431 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2009 | 49 | 0.080 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2023 | 250 | 0.080 |
Why?
|
| HEK293 Cells | 3 | 2019 | 646 | 0.080 |
Why?
|
| Mumps | 1 | 2008 | 2 | 0.080 |
Why?
|
| Mumps virus | 1 | 2008 | 3 | 0.080 |
Why?
|
| Somatotrophs | 1 | 2008 | 1 | 0.080 |
Why?
|
| Iron | 2 | 2020 | 168 | 0.080 |
Why?
|
| Transcription Factor Pit-1 | 1 | 2008 | 6 | 0.080 |
Why?
|
| Growth Hormone-Releasing Hormone | 1 | 2008 | 7 | 0.080 |
Why?
|
| Population Groups | 1 | 2008 | 41 | 0.080 |
Why?
|
| Tunisia | 1 | 2007 | 8 | 0.070 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2007 | 9 | 0.070 |
Why?
|
| Aged | 5 | 2024 | 19144 | 0.070 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2007 | 16 | 0.070 |
Why?
|
| Intestines | 2 | 2023 | 416 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2014 | 1227 | 0.070 |
Why?
|
| Nucleic Acid Conformation | 1 | 2009 | 345 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2009 | 245 | 0.070 |
Why?
|
| Disease Outbreaks | 1 | 2008 | 156 | 0.070 |
Why?
|
| Europe | 2 | 2022 | 322 | 0.070 |
Why?
|
| Homeostasis | 2 | 2020 | 417 | 0.070 |
Why?
|
| Mannose-Binding Lectin | 1 | 2006 | 3 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 885 | 0.070 |
Why?
|
| Pakistan | 1 | 2006 | 15 | 0.070 |
Why?
|
| Arylamine N-Acetyltransferase | 1 | 2006 | 12 | 0.070 |
Why?
|
| Molecular Epidemiology | 1 | 2006 | 54 | 0.070 |
Why?
|
| Africa, Central | 2 | 2017 | 5 | 0.070 |
Why?
|
| Lectins | 1 | 2006 | 84 | 0.060 |
Why?
|
| Genes, Bacterial | 1 | 2006 | 198 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2018 | 2763 | 0.060 |
Why?
|
| Adolescent | 4 | 2017 | 9299 | 0.060 |
Why?
|
| Genetic Speciation | 1 | 2006 | 115 | 0.060 |
Why?
|
| Isoenzymes | 1 | 2006 | 274 | 0.060 |
Why?
|
| Herpesvirus 1, Human | 1 | 2007 | 245 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2020 | 1576 | 0.060 |
Why?
|
| Africa | 2 | 2018 | 101 | 0.060 |
Why?
|
| Breeding | 1 | 2024 | 41 | 0.060 |
Why?
|
| Cattle | 1 | 2024 | 378 | 0.060 |
Why?
|
| Genetic Association Studies | 2 | 2017 | 294 | 0.060 |
Why?
|
| Interleukin-10 | 1 | 2025 | 155 | 0.060 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2024 | 44 | 0.060 |
Why?
|
| Noncommunicable Diseases | 1 | 2024 | 6 | 0.060 |
Why?
|
| Biological Assay | 1 | 2024 | 79 | 0.060 |
Why?
|
| Drug Synergism | 1 | 2024 | 307 | 0.060 |
Why?
|
| Interferon-alpha | 1 | 2024 | 214 | 0.050 |
Why?
|
| Organoids | 1 | 2023 | 63 | 0.050 |
Why?
|
| Actinobacillus | 1 | 2023 | 3 | 0.050 |
Why?
|
| Swine | 1 | 2024 | 588 | 0.050 |
Why?
|
| Prostaglandins E | 1 | 2023 | 19 | 0.050 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2023 | 16 | 0.050 |
Why?
|
| Denmark | 1 | 2022 | 17 | 0.050 |
Why?
|
| London | 1 | 2022 | 16 | 0.050 |
Why?
|
| Virulence | 1 | 2024 | 281 | 0.050 |
Why?
|
| Reproduction | 1 | 2024 | 199 | 0.050 |
Why?
|
| Aminopeptidases | 1 | 2022 | 17 | 0.050 |
Why?
|
| Arachidonate 12-Lipoxygenase | 1 | 2023 | 24 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2014 | 418 | 0.050 |
Why?
|
| Immunity, Mucosal | 1 | 2023 | 70 | 0.050 |
Why?
|
| Datasets as Topic | 1 | 2022 | 75 | 0.050 |
Why?
|
| Rats | 2 | 2024 | 4041 | 0.050 |
Why?
|
| Acute Lung Injury | 1 | 2023 | 64 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2024 | 469 | 0.050 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2021 | 13 | 0.050 |
Why?
|
| Interleukin-17 | 1 | 2023 | 105 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2022 | 331 | 0.050 |
Why?
|
| Autoantibodies | 1 | 2023 | 268 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2017 | 520 | 0.050 |
Why?
|
| Anti-Retroviral Agents | 1 | 2021 | 32 | 0.050 |
Why?
|
| Cell Division | 1 | 2023 | 692 | 0.050 |
Why?
|
| Animals, Newborn | 1 | 2023 | 524 | 0.050 |
Why?
|
| Viral Load | 1 | 2021 | 145 | 0.050 |
Why?
|
| Fibroblasts | 2 | 2018 | 758 | 0.050 |
Why?
|
| Butyric Acid | 1 | 2020 | 11 | 0.040 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2020 | 15 | 0.040 |
Why?
|
| Africa South of the Sahara | 2 | 2011 | 23 | 0.040 |
Why?
|
| Myeloid Cells | 1 | 2020 | 101 | 0.040 |
Why?
|
| Ligands | 1 | 2021 | 446 | 0.040 |
Why?
|
| Receptors, Interleukin-15 | 1 | 2019 | 8 | 0.040 |
Why?
|
| Hierarchy, Social | 1 | 2019 | 12 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2006 | 2878 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 155 | 0.040 |
Why?
|
| Gabon | 1 | 2019 | 1 | 0.040 |
Why?
|
| Cameroon | 1 | 2019 | 16 | 0.040 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2020 | 90 | 0.040 |
Why?
|
| History, Ancient | 2 | 2010 | 74 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2019 | 77 | 0.040 |
Why?
|
| Risk Factors | 2 | 2011 | 5523 | 0.040 |
Why?
|
| Cellular Reprogramming | 1 | 2019 | 41 | 0.040 |
Why?
|
| Duodenum | 1 | 2019 | 105 | 0.040 |
Why?
|
| Butyrophilins | 1 | 2019 | 22 | 0.040 |
Why?
|
| Intraepithelial Lymphocytes | 1 | 2019 | 16 | 0.040 |
Why?
|
| K562 Cells | 1 | 2018 | 44 | 0.040 |
Why?
|
| Social Stigma | 1 | 2019 | 68 | 0.040 |
Why?
|
| Dermis | 1 | 2018 | 28 | 0.040 |
Why?
|
| Age Factors | 2 | 2014 | 1877 | 0.040 |
Why?
|
| Pre-Exposure Prophylaxis | 1 | 2021 | 147 | 0.040 |
Why?
|
| Lactobacillus | 1 | 2018 | 21 | 0.040 |
Why?
|
| Diet, Gluten-Free | 1 | 2019 | 58 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2020 | 212 | 0.040 |
Why?
|
| Penetrance | 1 | 2018 | 45 | 0.040 |
Why?
|
| Linkage Disequilibrium | 2 | 2013 | 477 | 0.040 |
Why?
|
| Permeability | 1 | 2018 | 138 | 0.040 |
Why?
|
| Germ-Free Life | 1 | 2018 | 75 | 0.040 |
Why?
|
| Dioxygenases | 1 | 2018 | 77 | 0.040 |
Why?
|
| Syndrome | 1 | 2018 | 449 | 0.040 |
Why?
|
| Indicators and Reagents | 1 | 2017 | 72 | 0.040 |
Why?
|
| Reoviridae | 1 | 2017 | 6 | 0.040 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2017 | 20 | 0.040 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2018 | 135 | 0.040 |
Why?
|
| RNA, Bacterial | 1 | 2017 | 111 | 0.030 |
Why?
|
| Liver X Receptors | 1 | 2016 | 12 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2018 | 260 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2014 | 2063 | 0.030 |
Why?
|
| North America | 1 | 2017 | 184 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 153 | 0.030 |
Why?
|
| Freeze Drying | 1 | 2016 | 15 | 0.030 |
Why?
|
| Microbial Viability | 1 | 2016 | 32 | 0.030 |
Why?
|
| Speech | 1 | 2017 | 85 | 0.030 |
Why?
|
| Genetic Engineering | 1 | 2017 | 115 | 0.030 |
Why?
|
| Potassium Channels | 1 | 2018 | 346 | 0.030 |
Why?
|
| Fetus | 1 | 2017 | 232 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2019 | 465 | 0.030 |
Why?
|
| Genes | 2 | 2008 | 306 | 0.030 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2016 | 47 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2019 | 423 | 0.030 |
Why?
|
| DNA | 1 | 2022 | 1309 | 0.030 |
Why?
|
| Phospholipase D | 1 | 2015 | 13 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 1850 | 0.030 |
Why?
|
| Lipids | 1 | 2017 | 275 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2016 | 276 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2016 | 217 | 0.030 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2016 | 101 | 0.030 |
Why?
|
| Models, Animal | 1 | 2016 | 276 | 0.030 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2014 | 13 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 240 | 0.030 |
Why?
|
| Disease Reservoirs | 1 | 2014 | 21 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2017 | 725 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2015 | 354 | 0.030 |
Why?
|
| Africa, Western | 1 | 2014 | 11 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2015 | 244 | 0.030 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2014 | 95 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 278 | 0.030 |
Why?
|
| Amino Acids | 1 | 2014 | 246 | 0.030 |
Why?
|
| Morocco | 1 | 2013 | 17 | 0.030 |
Why?
|
| Madagascar | 1 | 2013 | 29 | 0.030 |
Why?
|
| Dogs | 1 | 2014 | 704 | 0.030 |
Why?
|
| Detergents | 1 | 2012 | 34 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2014 | 269 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2014 | 793 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2014 | 255 | 0.030 |
Why?
|
| Skull | 1 | 2014 | 255 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2015 | 774 | 0.020 |
Why?
|
| Mycobacterium Infections | 1 | 2011 | 15 | 0.020 |
Why?
|
| Biomarkers | 1 | 2017 | 1768 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2008 | 3754 | 0.020 |
Why?
|
| History | 1 | 2010 | 2 | 0.020 |
Why?
|
| Emigration and Immigration | 1 | 2010 | 48 | 0.020 |
Why?
|
| Child | 2 | 2013 | 7214 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 899 | 0.020 |
Why?
|
| Peptides | 1 | 2012 | 649 | 0.020 |
Why?
|
| Obesity | 1 | 2015 | 971 | 0.020 |
Why?
|
| Receptors, Pituitary Hormone-Regulating Hormone | 1 | 2008 | 2 | 0.020 |
Why?
|
| Sequence Homology | 1 | 2008 | 28 | 0.020 |
Why?
|
| Receptors, Neuropeptide | 1 | 2008 | 8 | 0.020 |
Why?
|
| Spain | 1 | 2008 | 32 | 0.020 |
Why?
|
| Untranslated Regions | 1 | 2008 | 18 | 0.020 |
Why?
|
| Serum | 1 | 2008 | 25 | 0.020 |
Why?
|
| S Phase | 1 | 2008 | 63 | 0.020 |
Why?
|
| Cricetulus | 1 | 2008 | 127 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2008 | 84 | 0.020 |
Why?
|
| CHO Cells | 1 | 2008 | 188 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2008 | 79 | 0.020 |
Why?
|
| Poly I-C | 1 | 2007 | 18 | 0.020 |
Why?
|
| China | 1 | 2008 | 235 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 123 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2007 | 117 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2008 | 126 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2008 | 274 | 0.020 |
Why?
|
| Cricetinae | 1 | 2008 | 558 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2008 | 275 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2008 | 318 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2011 | 1101 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2007 | 146 | 0.020 |
Why?
|
| Heterozygote | 1 | 2007 | 373 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2008 | 682 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2006 | 203 | 0.020 |
Why?
|
| Acetylation | 1 | 2006 | 132 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2008 | 1130 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2006 | 476 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2008 | 492 | 0.020 |
Why?
|
| Geography | 1 | 2006 | 227 | 0.020 |
Why?
|
| Time Factors | 1 | 2012 | 5333 | 0.010 |
Why?
|
| Infant | 1 | 2007 | 3174 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2006 | 898 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2013 | 9112 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 6766 | 0.010 |
Why?
|